Downstream gene activation of the receptor ALX by the agonist annexin A1

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-9

  Renshaw, Derek ^a   Montero Melendez, Trinidad ^a   Dalli, Jesmond ^a   Kamal, Ahmad ^a   Brancaleone, Vincenzo ^a,b   D'Acquisto, Fulvio ^a   Cirino, Giuseppe ^b   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID DERIVATIVE; CELL ADHESION MOLECULE; CELL MEMBRANE PROTEIN; GLUCOCORTICOID; HISTONE DEACETYLASE INHIBITOR; JAGGED1; LIPOCORTIN 1; MEMBRANE RECEPTOR; PROTEIN AC2 26; PROTEIN ALX RECEPTOR; PROTEIN JAM3; REGULATOR PROTEIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE PHOSPHATE PHOSPHATASE 2; UNCLASSIFIED DRUG; HSH2D PROTEIN, HUMAN; MEMBRANE PROTEIN; PHOSPHATASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SPHINGOSINE 1 PHOSPHATE PHOSPHATASE; SPHINGOSINE-1-PHOSPHATE PHOSPHATASE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN HEK293; CHEMOTAXIS; CONTROLLED STUDY; DOWNSTREAM PROCESSING; DRUG RECEPTOR BINDING; GENE ACTIVATION; GENE ACTIVITY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKOCYTE; LYMPH NODE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DRUG POTENTIATION; FEMALE; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PROTEIN BINDING;

MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; ANNEXIN A1; FEMALE; HEK293 CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN BINDING; UP-REGULATION;

EID: 77958546957     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012771     Document Type: Article

References (45)

1. Perretti M (1997) Endogenous mediators that inhibit the leukocyte-endothelium interaction. Trends in Pharmacological Sciences 18: 418-425.
2. Gilroy DW, Lawrence T, Perretti M, Rossi AG (2004) Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3: 401-416.
3. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, et al. (2007) Resolution of inflammation: state of the art, definitions and terms. Faseb J 21: 325-332.
4. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, et al. (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698-701.
5. Perretti M, Ahluwalia A, Harris JG, Goulding NJ, Flower RJ (1993) Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse: a qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol 151: 4306-4314.
6. Yang Y, Hutchinson P, Morand EF (1999) Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis Rheum 42: 1538-1544.
7. Damazo AS, Yona S, D'Acquisto F, Flower RJ, Oliani SM, et al. (2005) Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol 166: 1607-1617.
8. Chiang N, Serhan CN, Dahlen SE, Drazen JM, Hay DW, et al. (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 58: 463-487.
9. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, et al. (2009) International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61: 119-161.
10. Fu H, Karlsson J, Bylund J, Movitz C, Karlsson A, et al. (2006) Ligand recognition and activation of formyl peptide receptors in neutrophils. J Leukoc Biol 79: 247-256.
11. Perretti M, Chiang N, La M, Fierro IM, Marullo S, et al. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor. Nat Med 8: 1296-1302.
12. Perretti M, Solito E (2004) Annexin 1 and neutrophil apoptosis. Biochem Soc Trans 32: 507-510.
13. Perretti M, D'Acquisto F (2009) Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9: 62-70.
14. Ernst S, Lange C, Wilbers A, Goebeler V, Gerke V, et al. (2004) An annexin 1 N-terminal Peptide activates leukocytes by triggering different members of the formyl Peptide receptor family. J Immunol 172: 7669-7676.
15. Walther A, Riehemann K, Gerke V (2000) A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell 5: 831-840.
16. Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, et al. (2006) Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107: 2123-2130.
17. Gerke V, Creutz CE, Moss SE (2005) Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461.
18. Hannon R, Croxtall JD, Getting SJ, Roviezzo F, Yona S, et al. (2003) Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. Faseb J 17: 253-255.
19. Rosen H, Goetzl EJ (2005) Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5: 560-570.
20. Massberg S, von Andrian UH (2006) Fingolimod and sphingosine-1-phosphate- modifiers of lymphocyte migration. N Engl J Med 355: 1088-1091.
21. Mechtcheriakova D, Wlachos A, Sobanov J, Kopp T, Reuschel R, et al. (2007) Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal 19: 748-760.
22. Meng J, Ma X, Ma D, Xu C (2005) Microarray analysis of differential gene expression in temporomandibular joint condylar cartilage after experimentally induced osteoarthritis. Osteoarthritis Cartilage 13: 1115-1125.
23. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689.
24. Palmer G, Busso N, Aurrand-Lions M, Talabot-Ayer D, Chobaz-Peclat V, et al. (2007) Expression and function of junctional adhesion molecule-C in human and experimental arthritis. Arthritis Res Ther 9: R65.
25. Rabquer BJ, Pakozdi A, Michel JE, Gujar BS, Haines GK, 3rd, et al. (2008) Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum 58: 3020-3029.
26. Yang YH, Morand EF, Getting SJ, Paul-Clark MJ, Liu DL, et al. (2004) Modulation of inflammation and response to dexamethasone by annexin-1 in antigen-induced arthritis. Arthritis Rheum 50: 976-984.
27. D'Acquisto F, Merghani A, Lecona E, Rosignoli G, Raza K, et al. (2007) Annexin-1 modulates T-cell activation and differentiation. Blood 109: 1095-1102.
28. Elyaman W, Bradshaw EM, Wang Y, Oukka M, Kivisakk P, et al. (2007) JAGGED1 and delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis. J Immunol 179: 5990-5998.
29. D'Acquisto F (2009) On the adaptive nature of Annexin-A1. Curr Opin Pharmacol.
30. Lamb J (2007) The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 7: 54-60.
31. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929-1935.
32. Hieronymus H, Lamb J, Ross KN, Peng XP, Clement C, et al. (2006) Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 10: 321-330.
33. Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, et al. (2006) Gene expressionbased chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 10: 331-342.
34. Catania A, Colombo G, Rossi C, Carlin A, Sordi A, et al. (2006) Antimicrobial properties of alpha-MSH and related synthetic melanocortins. ScientificWorld- Journal 6: 1241-1246.
35. Charnley M, Moir AJ, Douglas CW, Haycock JW (2008) Anti-microbial action of melanocortin peptides and identification of a novel X-Pro-D/L-Val sequence in Gram-positive and Gram-negative bacteria. Peptides 29: 1004-1009.
36. Rempe S, Hayden JM, Robbins RA, Hoyt JC (2007) Tetracyclines and pulmonary inflammation. Endocr Metab Immune Disord Drug Targets 7: 232-236.
37. Nasu Y, Nishida K, Miyazawa S, Komiyama T, Kadota Y, et al. (2008) Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthritis Cartilage 16: 723-732.
38. Glauben R, Batra A, Fedke I, Zeitz M, Lehr HA, et al. (2006) Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol 176: 5015-5022.
39. Zhang B, West EJ, Van KC, Gurkoff GG, Zhou J, et al. (2008) HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res 1226: 181-191.
40. Tabe Y, Jin L, Contractor R, Gold D, Ruvolo P, et al. (2007) Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death Differ 14: 1443-1456.
41. Maderna P, Yona S, Perretti M, Godson C (2005) Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac2-26. J Immunol 174: 3727-3733.
42. Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, et al. (2007) Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 178: 4595-4605.
43. Petrella A, D'Acunto CW, Rodriquez M, Festa M, Tosco A, et al. (2008) Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1. Eur J Cancer 44: 740-749.
44. D'Acquisto F, Perretti M, Flower RJ (2008) Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol 155: 152-169.
45. Chatterjee BE, Yona S, Rosignoli G, Young RE, Nourshargh S, et al. (2005) Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J Leukoc Biol 78: 639-646.